Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Clinical trial NCT02684461 · COMPLETED
Trial details
- NCT number
- NCT02684461
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-13
- Primary completion
- 2021-11-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.